erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
family slam health trust after pensioner's 'undignified' death.
scottish widows has its eyes on the master trust prize.